Royce & Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,000
| Closed | -$177K | – | 1207 |
|
|
2020
Q2 | $177K | Sell |
12,000
-19,100
| -61% | -$282K | ﹤0.01% | 949 |
|
|
2020
Q1 | $128K | Hold |
31,100
| – | – | ﹤0.01% | 957 |
|
|
2019
Q4 | $150K | Hold |
31,100
| – | – | ﹤0.01% | 982 |
|
|
2019
Q3 | $188K | Sell |
31,100
-45,000
| -59% | -$272K | ﹤0.01% | 981 |
|
|
2019
Q2 | $494K | Hold |
76,100
| – | – | ﹤0.01% | 909 |
|
|
2019
Q1 | $540K | Hold |
76,100
| – | – | ﹤0.01% | 918 |
|
|
2018
Q4 | $370K | Sell |
76,100
-12,600
| -14% | -$61.3K | ﹤0.01% | 950 |
|
|
2018
Q3 | $652K | Hold |
88,700
| – | – | ﹤0.01% | 962 |
|
|
2018
Q2 | $566K | Sell |
88,700
-14,700
| -14% | -$93.8K | ﹤0.01% | 1010 |
|
|
2018
Q1 | $562K | Buy |
103,400
+37,500
| +57% | +$204K | ﹤0.01% | 1040 |
|
|
2017
Q4 | $275K | Buy |
+65,900
| New | +$275K | ﹤0.01% | 1076 |
|